Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
Recruitment status was: Not yet recruiting
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Prevention
|Official Title:||A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects|
- Bite lesion size (squared mm)
- Pruritus on a Visual Analog Scale
Mosquito-bite symptoms include wheals and pruritic bite papules. Oral antihistamines have shown to decrease whealing ang accompanying pruritus in placebo-controlled trials.
Subjects will be treated for 4 days, and exposed to experimental mosquito bite at day 3.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00258141
|Koskiklinikka, Tampere Lääkärikeskus|
|Tampere, Finland, 33101|
|Principal Investigator:||Timo Reunala, Prof.||Medical School, University of Tampere and Tampere University Hospital|